Reply
- PMID: 40693604
- DOI: 10.1097/DCR.0000000000003903
Reply
References
-
- Vedovati MC, Becattini C, Rondelli F, et al. A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg. 2014;259:665–669.
-
- Becattini C, Pace U, Pirozzi F, et al. Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer. Blood. 2022;140:900–908.
-
- Felder S, Rasmussen MS, King R, et al. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev. 2019;3:CD004318.
-
- NCCN. Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Cancer-associated venous thromboembolic disease. Version 2. 2025. https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1423 . Accessed May 2025.
-
- Raskob GE, Spyropoulos AC, Cohen AT, et al. Association between asymptomatic proximal deep vein thrombosis and mortality in acutely ill medical patients. J Am Heart Assoc. 2021;10:e019459.
LinkOut - more resources
Full Text Sources